By crossing CD18fl/fl mice with transgenic mice expressing Cre recombinase under control of the PMN-specific (Ly6GCre+) promoter, offspring with a PMN-specific knockdown of CD18 have been generated, thus allowing to analyze the PMN-specific role in IPA. The gene discussed is ITGB2; the disease is Ito hypomelanosis.